Risk factor
Considerable default risk
Profitability factor
Favourable analyst view
About
Chrysos Corporation Limited is dedicated to creating and delivering advanced solutions for the mining industry. Established in 2016 and based in Adelaide, Australia, the company's flagship product is PhotonAssay. This innovative technology enables the accurate and efficient analysis of elements such as gold, silver, and copper, among others.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
Target Price
The average target price of C79.AX is 9.58 and suggests 45.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in